www.praktickelekarenstvi.cz e35 PRAKTICKÉ LÉKÁRENSTVÍ AKTUÁLNÍ FARMAKOTERAPIE Kariprazin v léčbě schizofrenie 13. https://postupy-pece.psychiatrie.cz/specialni-psychiatrie/f2-schizofrenie/stabilizacni- -udrzovaci-lecba-schizofrenie. 14. Cerveri G, Gesi C, Mencacci C. Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm. Neuropsychiatr Dis Treat 2019; 15: 1525–1535. 15. Orsolini L, De Berardis D, Volpe U. Up-to-date expert opinion on the safety of recently developed antipsychotics. Expert Opin Drug Saf 2020; 19: 981–998. 16. Fagiolini A, Alcalá JÁ, Aubel T, et al. Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel. Ann Gen Psychiatry 2020; 19: 55. 17. https://www.medicines.org.uk/emc/product/9401/smpc. 18. Szatmári B, Barabássy Á, Harsányi J, Laszlovszky I, Sebe B, Gál M, Shiragami K, Németh G. Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data. Front Psychiatry 2020; 11: 61. 19. Citrome L. Aripiprazole, brexpiprazole, and cariprazine: Not all the same. Current Psychiatry 2018; 17: 24–33, 43.
RkJQdWJsaXNoZXIy NDA4Mjc=